Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: Is there a role for early bone marrow transplantation?

被引:7
作者
Pasic, S
Minic, A
Minic, P
Veljkovic, D
Lilic, D
Slavkovic, B
Pejnovic, N
Abinun, M
机构
[1] Mother & Child Hlth Inst Serbia, Dept Pediat Immunol, YU-11070 Belgrade, Serbia
[2] Mother & Child Hlth Inst Serbia, Dept Pulm, YU-11070 Belgrade, Serbia
[3] Mother & Child Hlth Inst Serbia, Dept Transfus, YU-11070 Belgrade, Serbia
[4] Univ Newcastle, Dept Microbiol & Immunol, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England
[5] Mil Med Acad, Dept Expt Immunol, YU-11002 Belgrade, Serbia
[6] Newcastle Gen Hosp, Dept Paediat, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
关键词
chronic granulomatous disease; children; prognosis; bone marrow transplantation;
D O I
10.1023/A:1021952315651
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report the long-term follow-up of 12 pediatric-aged patients with chronic granulomatous disease (CGD). The mean age at the onset of infections was 5 months with a median delay in diagnosis of 2.5 years. Bacille Calmette-Guerin lymphadenitis was the most common presenting infection (6) followed by suppurative lymphadenitis (4), liver abscess (1), or Salmonella sepsis (1). Prophylaxis with cotrimoxazole was recommended to all patients. During the mean follow-up of 10 years (range, 423 years) pneumonitis was the most prevalent infection (91%) followed by lymphadenitis (83%), aphtous stomatitis (58%), and liver abscesses (25%). Seven (58%) patients developed chronic lung disease due to grossly delayed diagnosis (3) or poor compliance with antimicrobial prophylaxis (4). Five (41%) patients died during the second decade of life of aspergillosis (3) or chronic lung disease (2). Probability of survival into the third decade of life was estimated to be only 19%. We argue that HLA-identical bone marrow transplantation (BMT), if possible, should be attempted at early age because of significant morbidity and mortality in adolescence. BMT also should be considered in patients who suffer severe infections despite antimicrobial prophylaxis or patients with evidence of chronic lung disease. Possibility of elective BMT from unrelated donors remains to be carefully evaluated.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 41 条
[1]   Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation [J].
Bielorai, B ;
Toren, A ;
Wolach, B ;
Mandel, M ;
Golan, H ;
Neumann, Y ;
Kaplinisky, C ;
Weintraub, M ;
Keller, N ;
Amariglio, N ;
Paswell, J ;
Rechavi, G .
BONE MARROW TRANSPLANTATION, 2000, 26 (09) :1025-1028
[2]   Follow up of patients with chronic granulomatous disease diagnosed since 1990 [J].
Cale, CM ;
Jones, AM ;
Goldblatt, D .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (02) :351-355
[3]   IMMUNOLOGICAL CONDITIONS OF CHILDREN WITH BCG DISSEMINATED INFECTION [J].
CASANOVA, JL ;
JOUANGUY, E ;
LAMHAMEDI, S ;
BLANCHE, S ;
FISCHER, A .
LANCET, 1995, 346 (8974) :581-581
[4]  
DIBARTOLOMEO P, 1989, BONE MARROW TRANSPL, V4, P695
[5]   Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome [J].
Eppinger, TM ;
Greenberger, PA ;
White, DA ;
Brown, AE ;
Cunningham-Rundles, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) :1265-1272
[6]   A CONTROLLED TRIAL OF INTERFERON-GAMMA TO PREVENT INFECTION IN CHRONIC GRANULOMATOUS-DISEASE [J].
EZEKOWITZ, RAB .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (08) :509-516
[7]   PROGNOSIS OF CHRONIC GRANULOMATOUS-DISEASE [J].
FINN, A ;
HADZIC, N ;
MORGAN, G ;
STROBEL, S ;
LEVINSKY, RJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (09) :942-945
[8]   THE MANAGEMENT OF CHRONIC GRANULOMATOUS-DISEASE [J].
FISCHER, A ;
SEGAL, AW ;
SEGER, R ;
WEENING, RS .
EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (11) :896-899
[9]  
FISCHER A, 1994, BLOOD, V83, P1149
[10]   Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease [J].
Foster, CB ;
Lehrnbecher, T ;
Mol, F ;
Steinberg, SM ;
Venzon, DJ ;
Walsh, TJ ;
Noack, D ;
Rae, J ;
Winkelstein, JA ;
Curnutte, JT ;
Chanock, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) :2146-2155